Cytogenetically, AFST is characterized by balanced chromosomal translocation t (5;8) (p15;q13) resulting in formation of the tumor-specific fusion gene AHRR–NCOA2 (1, 5–7, 9, 14). The gene discussed is NCOA2; the disease is neoplasm.